Phytoene.

Phytoene desaturase converts phytoene directly into phytofluene, so the two always occur together in tomato and carrot material. They also absorb in adjacent parts of the ultraviolet range.

Phytoene is the first committed carotenoid in the route that runs through phytofluene and zeta-carotene to lycopene. Colourless carotenoid extracts carry all of these as a set.

Desaturation and isomerisation of phytoene ultimately yield all-trans-lycopene. The two travel in the same lipid micelle and the same tomato oleoresin.

Carotenoids compete for space in mixed micelles and for the SR-B1 transporter at the enterocyte. Large beta-carotene doses reduce uptake of the colourless carotenoids taken with them.

Lutein and the hydrocarbon carotenoids draw on the same micelle capacity and the same intestinal transporters. High doses of one lower the fraction absorbed of the other.

Whole tomato and palm extracts deliver phytoene alongside phytofluene, lycopene and the carotenes in their native ratio. Formulators use the complex to keep that spread rather than isolate one band.

Phytoene is a highly lipophilic hydrocarbon that only reaches the enterocyte inside a mixed micelle. Taking it with a lipid load raises the fraction absorbed.

Tocopherols intercept lipid peroxyl radicals in the same membrane compartment where carotenoids sit, which spares the conjugated polyene chain from oxidation. The pair keeps carotenoid material intact in the capsule and in tissue.

Plant sterols crowd cholesterol and carotenoids out of mixed micelles, the same mechanism behind their effect on sterol uptake. Regular sterol intake lowers circulating carotenoid levels including the colourless ones.

Both are carotenoids that sit in lipid environments and quench singlet oxygen and lipid radicals, but they park at different depths in a membrane because astaxanthin carries polar end groups and phytoene does not. Formulators pair them to cover more of the lipid phase than either does alone. The reasoning is structural rather than drawn from a head-to-head combination trial.

Carotenoids share the same mixed-micelle route and the same intestinal transporters, so a large dose of one can reduce uptake of another taken at the same time. Xanthophylls such as zeaxanthin and hydrocarbon carotenes such as phytoene do not compete equally, but the pathway overlap is real. Spacing doses or accepting a lower per-carotenoid uptake is the usual formulation choice.

Phytoene is a pure hydrocarbon with no polar group at all, so it cannot enter an aqueous phase without being carried in a bile-salt mixed micelle. Bile acids are what solubilise it for uptake by the enterocyte. Where bile flow is low, the limiting step is solubilisation rather than the dose on the label.

Carotenoid absorption depends on the fat around it being hydrolysed so a mixed micelle can form. Lipase does that hydrolysis. An oil-suspended carotenoid taken with poor lipolysis is presented to the gut wall in a form it cannot take up efficiently.

Phospholipids emulsify a lipophilic carotenoid into fine droplets and stabilise the interface, which is why lecithin appears in most carotenoid beadlet and emulsion systems. Smaller droplets present more surface area to lipase and bile. This is formulation practice with a clear physical basis.

As the main phospholipid in lecithin, phosphatidylcholine forms the bilayer or interfacial film that carries a hydrocarbon carotenoid in an aqueous product. Liposomal carotenoid preparations use exactly this. The gain is in dispersion and stability, not in changing what the carotenoid does once absorbed.

Taking a carotenoid with a meaningful amount of dietary fat raises how much of it reaches the circulation, and an omega-3 oil in the same capsule supplies that fat. The counter-consideration is that highly unsaturated oils oxidise, so the pairing usually needs an antioxidant in the oil phase. Both points are formulation physics rather than a clinical claim.

Tocotrienols intercept lipid peroxyl radicals in the membrane while colourless carotenoids act mainly on singlet oxygen and early-stage lipid oxidation. Working on different steps of the same chain reaction, they protect the oil phase of a product as well as the lipid it ends up in. Laboratory oxidation models support the direction; human outcome data for the combination is not established.

Ascorbate operates in the water phase and regenerates oxidised antioxidants at the lipid-water interface, which is the classic partner arrangement for a lipid-soluble carotenoid. The recycling loop is well described for vitamin E; for colourless carotenoids it is inferred from the same chemistry rather than measured directly. Read it as mechanistic rather than clinical.

Phytoene is the first committed carotenoid in the plant pathway that eventually produces lycopene and then beta-carotene, the provitamin A carotenoid. Humans lack the desaturase enzymes that carry out those steps, so phytoene taken by mouth is not a source of vitamin A. Anyone reading the biosynthetic diagram should note where the human pathway stops.

Squalane is a saturated hydrocarbon oil that dissolves hydrocarbon carotenoids well and does not itself oxidise readily, which suits a colourless carotenoid intended for a topical or a stable oil-phase product. It functions as the carrier, not as an active in the pairing. The choice is about oxidative stability of the vehicle.

Carotenoids in an oil matrix degrade through oxidation and isomerisation, and mixed tocopherols are the standard in-oil stabiliser used to slow that. The benefit is to the shelf life of the delivered carotenoid rather than to a physiological effect. It is why almost every carotenoid oleoresin ships with tocopherols already in it.